Wellington Management Group Llp Increased Its Stake in Bristol Myers Squibb Co (BMY) by $8.42 Billion

May 17, 2018 - By Julia Grubbs

Bristol-Myers Squibb Company (NYSE:BMY) Corporate LogoBig Money Sentiment decreased to 0.94 in Q4 2017. It has change of 0.09, from 2017Q3’s 1.03. The ratio fall due to BMY positioning: 72 sold and 526 reduced. 106 funds acquired stakes and 457 increased stakes. Investors holded 1.11 billion in 2017Q3 but now own 1.11 billion shares or 0.48% more. Huntington Bank & Trust holds 0.53% or 541,149 shs in its capital. Hyman Charles D owns 185,771 shs. Pinebridge LP accumulated 0% or 1,942 shs. Pinnacle Wealth Management Advisory Lc holds 0.81% of its capital in Bristol-Myers Squibb Company (NYSE:BMY) for 23,833 shs. L S Advsr stated it has 0.05% in Bristol-Myers Squibb Company (NYSE:BMY). Bbva Compass Comml Bank holds 0.05% of its capital in Bristol-Myers Squibb Company (NYSE:BMY) for 12,504 shs. Oarsman reported 3,750 shs. Mcrae Cap Management holds 3,600 shs or 0.09% of its capital. Axa reported 371,586 shs. Laurion Mgmt LP has invested 0.07% in Bristol-Myers Squibb Company (NYSE:BMY). Davenport Lc accumulated 1.19M shs or 0.87% of the stock. 32,142 are held by Dorsey And Whitney Trust Com Ltd Liability Com. Moreover, Comml Bank Of Nova Scotia Com has 0.03% invested in Bristol-Myers Squibb Company (NYSE:BMY). Ntv Asset Mgmt Lc holds 35,467 shs. Winslow Asset Management stated it has 5,606 shs.

BMY had 1 insider sale and 2 buys since December 12, 2017. This’s net activity of $163,963. The insider Lynch Thomas J. Jr. sold $335,172. Paliwal Dinesh C also bought $249,948 worth of Bristol-Myers Squibb Company (NYSE:BMY) on Monday, April 30.

Based on the latest 2017Q4 regulatory filing with the SEC, Wellington Management Group Llp increased its holdings in Bristol Myers Squibb Co (BMY) by 5762516.82%. The company’s stock popped up 2.38% while Wellington Management Group Llp bought 138.07M shares. The major pharmaceuticals company reported $8.46 billion value for the 2017Q4. Now the institutional investor is holding 138.07M shares, compared to the 2,396 from the previous quarter. $85.36 billion is the market cap of Bristol Myers Squibb Co. The stock decreased 0.17% or $0.09 during the last trading session, touching $52.21.Currently Bristol-Myers Squibb Company is uptrending after 11.37% change in last May 17, 2017. BMY has also 5.42M shares volume. BMY underperformed the S&P 500 by 0.18%.

A portfolio of $452.59 billion is managed by Wellington Management Group Llp. As it’s registered in Securities and Exchange filling the stake in Pentair Plc (NYSE:PNR) is reduced by 795,716 shares to 2.37 million shares. They are valued at $167.57M in 2017Q4. Wellington Management Group Llp has cut its stake in Alleghany Corp Del (NYSE:Y) and also reduced its holding in Chubb Limited by 186,655 shares in the quarter, for a total of 28.21M shares.

For more Bristol-Myers Squibb Company (NYSE:BMY) news released recently go to: Streetinsider.com, Bizjournals.com, Seekingalpha.com, Seekingalpha.com or Fool.com. The titles are as follows: “Bristol-Myers Squibb (BMY) Highlights Breadth of Immuno-Oncology–Based Combination Research and Commitment …” released on May 16, 2018, “How Bristol-Myers Squibb’s new Peninsula digs boost its battle to beat cancer” on May 01, 2018, “Don’t Buy L Brands – Cramer’s Lightning Round (5/15/18)” with a publish date: May 16, 2018, “Ziopharm, Trump’s Drug Pricing Plan And The Future Of Expensive Drug Development” and the last “Why Bristol-Myers Squibb Stock Crashed in April” with publication date: May 09, 2018.

Bristol-Myers Squibb Company (NYSE:BMY) Ratings Coverage

Total analysts of 11 have positions in Bristol Myers (NYSE:BMY) as follows: 4 rated it a “Buy”, 0 with “Sell” and 7 with “Hold”. The positive are 36%. The firm has $78.0 highest while $47 is the lowest target. The average target $65.56 is 25.57% above the last ($52.21) price. Since February 6, 2018 according to StockzIntelligence Inc Bristol Myers has 17 analyst reports. On Thursday, February 15 the firm has “Overweight” rating given by Morgan Stanley. On Monday, March 5 the stock has “Neutral” rating by Bank of America. On Friday, April 13 Jefferies maintained Bristol-Myers Squibb Company (NYSE:BMY) with “Hold” rating. The stock rating was upgraded by BMO Capital Markets to “Market Perform” on Friday, April 27. On Tuesday, February 6 Leerink Swann maintained Bristol-Myers Squibb Company (NYSE:BMY) rating. Leerink Swann has “Buy” rating and $76.0 target. On Tuesday, February 6 the stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Underperform” rating given by BMO Capital Markets. On Wednesday, April 18 the stock has “Underperform” rating by BMO Capital Markets. On Wednesday, February 28 the rating was downgraded by DZ Bank to “Hold”. On Friday, March 23 Jefferies maintained Bristol-Myers Squibb Company (NYSE:BMY) rating. Jefferies has “Hold” rating and $7000 target. On Friday, February 16 the firm earned “Buy” rating by Citigroup.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: